Nasdaq:US$13.13 (-0.20) | HKEX:HK$20.30 (-0.52) | AIM:£1.97 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma